BERKELEY, Calif. and MAINZ, Germany, June 10, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ...
The NCI grant is allowing Xu’s team to continue dissecting the interactions among Lfng, Notch3, and other key signaling pathways involved in PDAC initiation and progression. The goal is to translate ...
Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...
More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 did not undergo testing for BRCA mutations, according to a retrospective analysis.Less than half ...
BioMark Diagnostics ( ($TSE:BUX) ) has provided an announcement. BioMark Diagnostics Inc. and its research partners have been honored with the ...
Early detection of prostate cancer could soon be simplified, thanks to a University of Otago – Ōtākou Whakaihu Waka project.
Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting ...
Early detection improves outcomes from almost all cancers. However, there is currently no screening program for most cancers ...
Lung Cancer Diagnostics Market OverviewThe global lung cancer diagnostics market is undergoing significant expansion as healthcare systems, technology developers, and research institutions intensify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback